Press Releases

Applications open for Discovery Park’s oncology themed ‘Discovery Spark’ programme Prize package worth over £50,000, including free lab or office space for one year at Discovery Park and support from a number of specialist partners. First prize business...

As we navigate what the future of healthcare will look like, it’s clear that technology will play a pivotal role. Specially, artificial intelligence (AI) is set to be a critical tool used in reshaping how pharma companies operate, engage...

3-year grant received from the Bill & Melinda Gates Foundation to enhance RNA production technologies Grant enables global implementation of the RNA Continuous Manufacturing platform and advancement of Process Analytical Technologies (PAT), developed through an MIT project funded...

Swiss Airtainer is pleased to announce the successful completion of its first 50 commercial shipments of high-value life science products. These shipments have demonstrated the performance, sustainability, and cost-efficiency of Swiss Airtainer’s RKN temperature-controlled containers in real-world operations and marks a significant achievement in the company’s mission to provide the pharmaceutical industry with sustainable and...

Luxembourg / London / New York / Boston / Paris – Following Astorg’s recent take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business (“Cook Medical RH”), the newly combined global leader in assisted reproductive technology...

New portfolio comprises innovative collagen solutions for parenteral applications, medical devices and 3D bioprinting GELITA, a leading manufacturer of collagen and gelatin, proudly announces the launch of its Endotoxin Controlled Excipients (ECE) portfolio. This cutting-edge product line, featuring VACCIPRO® and MEDELLAPRO®, meets the stringent demands of...

The use of antibody-drug-conjugates (ADC) in drug development is becoming more and more widespread, thanks to their potential to improve the effectiveness of cancer treatments by enabling more precise targeting of cancerogenic cells. ADCs harness a mechanism based on...